"Cholinergic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.
| Descriptor ID |
D018680
|
| MeSH Number(s) |
D27.505.519.625.120.200 D27.505.696.577.120.200
|
| Concept/Terms |
Cholinergic Antagonists- Cholinergic Antagonists
- Antagonists, Cholinergic
- Cholinergic Antagonist
- Antagonist, Cholinergic
- Cholinergic-Blocking Agents
- Agents, Cholinergic-Blocking
- Cholinergic Blocking Agents
- Cholinolytics
- Acetylcholine Antagonists
- Antagonists, Acetylcholine
- Cholinergic Receptor Antagonists
- Antagonists, Cholinergic Receptor
- Receptor Antagonists, Cholinergic
Anticholinergic Agents- Anticholinergic Agents
- Agents, Anticholinergic
- Anticholinergics
- Anti-Cholinergics
- Anti Cholinergics
|
Below are MeSH descriptors whose meaning is more general than "Cholinergic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Cholinergic Antagonists".
This graph shows the total number of publications written about "Cholinergic Antagonists" by people in this website by year, and whether "Cholinergic Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholinergic Antagonists" by people in Profiles.
-
Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging. J Alzheimers Dis. 2022; 86(1):53-65.
-
Anticholinergic medication burden and cognitive function in participants of the ASPREE study. Pharmacotherapy. 2022 02; 42(2):134-144.
-
Do Inhaled Anticholinergic Agents in Addition to ?-Agonists Improve Outcomes in Acute Asthma Exacerbations? Ann Emerg Med. 2017 09; 70(3):421-422.
-
Cognitive decline in older persons initiating anticholinergic medications. PLoS One. 2013; 8(5):e64111.
-
GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis. J Neuroimmunol. 2011 Dec 15; 240-241:65-73.
-
Mild cognitive impairment. Lancet. 2006 Apr 15; 367(9518):1262-70.
-
Therapeutic approaches. Adv Neurol. 2000; 82:217-21.
-
Pharmacological therapy in progressive supranuclear palsy. Arch Neurol. 1998 Aug; 55(8):1099-102.